NASDAQ:DOX - Amdocs Stock Price, Forecast & News

Amdocs' stock was trading at $61.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DOX shares have decreased by 15.6% and is now trading at $51.86. View which stocks have been mosted impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Amdocs.

Amdocs is scheduled to release its next quarterly earnings announcement on Tuesday, May 12th 2020. View our earnings forecast for Amdocs.

Amdocs Limited (NASDAQ:DOX) issued its quarterly earnings data on Tuesday, February, 4th. The technology company reported $1.06 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.01. The technology company earned $1.04 billion during the quarter, compared to analyst estimates of $1.03 billion. Amdocs had a return on equity of 16.13% and a net margin of 11.99%. The business's revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.98 earnings per share. View Amdocs' earnings history.

Amdocs declared a quarterly dividend on Tuesday, February 4th. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.327 per share on Friday, April 24th. This represents a $1.31 annualized dividend and a dividend yield of 2.52%. The ex-dividend date is Monday, March 30th. This is a boost from Amdocs's previous quarterly dividend of $0.29. View Amdocs' dividend history.

Amdocs updated its FY20 earnings guidance on Tuesday, February, 4th. The company provided EPS guidance of $4.44-4.61 for the period, compared to the Thomson Reuters consensus estimate of $4.52. The company issued revenue guidance of $4.19-4.31 billion, compared to the consensus revenue estimate of $4.22 billion.

5 Wall Street analysts have issued 1 year price objectives for Amdocs' shares. Their forecasts range from $72.00 to $85.00. On average, they expect Amdocs' stock price to reach $77.80 in the next year. This suggests a possible upside of 50.0% from the stock's current price. View analysts' price targets for Amdocs.

Media coverage about DOX stock has been trending extremely negative on Sunday, according to InfoTrie. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Amdocs earned a daily sentiment score of -4.0 on InfoTrie's scale. They also gave media headlines about the technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutAmdocs.

Amdocs saw a drop in short interest during the month of March. As of March 13th, there was short interest totaling 3,580,000 shares, a drop of 12.3% from the February 27th total of 4,080,000 shares. Based on an average daily trading volume, of 1,117,400 shares, the days-to-cover ratio is currently 3.2 days. Currently, 2.7% of the shares of the stock are short sold. View Amdocs' Current Options Chain.

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), Leidos (LDOS), EPAM Systems (EPAM), Booz Allen Hamilton (BAH), Gartner (IT), Caci International (CACI), Mantech International (MANT), Teradata (TDC), Virtusa (VRTU), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and Servicesource International (SREV).

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include AbbVie (ABBV), AT&T (T), QUALCOMM (QCOM), Home Depot (hd), Intel (INTC), Caterpillar (CAT), Enterprise Products Partners (EPD), Target (TGT), Verizon Communications (VZ) and Activision Blizzard (ATVI).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by a number of retail and institutional investors. Top institutional shareholders include FMR LLC (11.85%), Janus Henderson Group PLC (5.60%), Massachusetts Financial Services Co. MA (3.11%), LSV Asset Management (2.56%), Beutel Goodman & Co Ltd. (2.14%) and AQR Capital Management LLC (2.00%).

DOX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Echo Street Capital Management LLC, Alliancebernstein L.P., Barclays PLC, Goldman Sachs Group Inc., Janus Henderson Group PLC, PGGM Investments, and Eaton Vance Management.

DOX stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Bessemer Group Inc., Schroder Investment Management Group, Acadian Asset Management LLC, AJO LP, Stifel Financial Corp, Anchor Capital Advisors LLC, and Citigroup Inc..

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $51.86.

Amdocs has a market capitalization of $6.99 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe. View additional information about Amdocs.

The official website for Amdocs is http://www.amdocs.com/.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]